CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials

Bioengineered

Volumn 8, Issue 3, 2017, Pages 280-286

  Kick, Leonhard ^a   Kirchner, Marion ^a   Schneider, Sabine ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

bacterial immune system; clinical trials; CRISPR Cas; genome editing

Indexed keywords

BIOMEDICINE; CHINA; CLINICAL TRIAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNA MODIFICATION; GENE EDITING; HUMAN; HUMAN CELL; NONHUMAN; PATENT; PERSONALIZED MEDICINE; SPECIES; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE; ADAPTIVE IMMUNITY; BACTERIUM; CLINICAL TRIAL (TOPIC); CRISPR CAS SYSTEM; GENETICS; IMMUNOLOGY; PROCEDURES;

ADAPTIVE IMMUNITY; BACTERIA; CLINICAL TRIALS AS TOPIC; CRISPR-CAS SYSTEMS; GENE EDITING; HUMANS;

EID: 85017170951     PISSN: 21655979     EISSN: 21655987     Source Type: Journal    
DOI: 10.1080/21655979.2017.1299834     Document Type: Review

References (46)

1. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol 1987; 169:5429-33; PMID:3316184; https://doi.org/10.1128/jb.169.12.5429-5433.1987
2. Jansen R, Embden JD, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol 2002; 43:1565-75; PMID:11952905; https://doi.org/10.1046/j.1365-2958.2002.02839.x
3. Mojica FJ, Diez-Villasenor C, Soria E, Juez G. Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria. Mol. Microbiol 2000; 36:244-6; PMID:10760181; https://doi.org/10.1046/j.1365-2958.2000.01838.x
4. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 2005; 151:2551-61; https://doi.org/10.1099/mic.0.28048-0
5. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007; 315:1709-12; PMID:17379808; https://doi.org/10.1126/science.1138140
6. Groenen PM, Bunschoten AE, van Soolingen D, van Embden JD. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol. Microbiol 1993; 10:1057-65; PMID:7934856; https://doi.org/10.1111/j.1365-2958.1993.tb00976.x
7. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 2005; 151:653-63; https://doi.org/10.1099/mic.0.27437-0
8. Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, van der Oost J. The CRISPRs, they are a-changin':how prokaryotes generate adaptive immunity. Annu. Rev. Genet 2012; 46:311-39; PMID:23145983; https://doi.org/10.1146/annurev-genet-110711-155447
9. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010; 468:67-71; PMID:21048762; https://doi.org/10.1038/nature09523
10. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337:816-21; PMID:22745249; https://doi.org/10.1126/science.1225829
11. Sakuma T, Nishikawa A, Kume S, Chayama K, Yamamoto T. Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system. Sci. Rep 2014; 4:5400; PMID:24954249; https://doi.org/10.1038/srep05400
12. Noman A, Aqeel M, He S. CRISPR-Cas9:tool for qualitative and quantitative plant genome editing. Front. Plant Sci 2016; 7:1740; PMID:27917188; https://doi.org/10.3389/fpls.2016.01740
13. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013 Jul 18; 154(2):442-451; https://doi.org/10.1016/j.cell.2013.06.044
14. Bortesi L, Zhu C, Zischewski J, Perez L, Bassie L, Nadi R, Forni G, Lade SB, Soto E, Jin X, et al. Patterns of CRISPR/Cas9 activity in plants, animals and microbes. Plant Biotechnol. J 2016; 14:2203-16; PMID:27614091; https://doi.org/10.1111/pbi.12634
15. Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, et al. Discovery and functional characterization of diverse Class 2 CRISPR-Cas systems. Mol. Cell 2015; 60:385-97; PMID:26593719; https://doi.org/10.1016/j.molcel.2015.10.008
16. Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 2016; 353:aaf5573; PMID:27256883
17. Fonfara I, Richter H, Bratovic M, Le Rhun A, Charpentier E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 2016; 532:517-21; PMID:27096362; https://doi.org/10.1038/nature17945
18. Pawluk A, Amrani N, Zhang Y, Garcia B, Hidalgo-Reyes Y, Lee J, Edraki A, Shah M, Sontheimer EJ, Maxwell KL, et al. Naturally occurring off-switches for CRISPR-Cas9. Cell 2016; 167:1829-38 e9; PMID:27984730; https://doi.org/10.1016/j.cell.2016.11.017
19. Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A. 2012 Sep 25; 109(39):E2579-E2586.
20. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol 2015; 13:722-36; PMID:26411297; https://doi.org/10.1038/nrmicro3569
21. Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, van der Oost J. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science 2016; 353:aad5147; PMID:27493190
22. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 2013; 10:1116-21; PMID:24076762; https://doi.org/10.1038/nmeth.2681
23. Bondy-Denomy J, Garcia B, Strum S, Du M, Rollins MF, Hidalgo-Reyes Y, Wiedenheft B, Maxwell KL, Davidson AR, Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature 2015; 526:136-9; PMID:26416740; https://doi.org/10.1038/nature15254
24. Pawluk A, Staals RH, Taylor C, Watson BN, Saha S, Fineran PC, Maxwell KL, Davidson AR, Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat. Microbiol 2016; 1:16085; PMID:27573108; https://doi.org/10.1038/nmicrobiol.2016.85
25. Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 2015; 6:363-72; PMID:25894090; https://doi.org/10.1007/s13238-015-0153-5
26. Generoso WC, Gottardi M, Oreb M, Boles E. Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae. J. Microbiol. Methods 2016; 127:203-5; PMID:27327211; https://doi.org/10.1016/j.mimet.2016.06.020
27. Krappmann S. CRISPR-Cas9, the new kid on the block of fungal molecular biology. Med. Mycol 2017; 55:16-23; PMID:27811178; https://doi.org/10.1093/mmy/myw097
28. Espacenet:free access to the database of over 90 million patents, https://worldwide.espacenet.com, search pattern “txt = crispr AND (txt = cas OR txt = cas9).
29. Waltz E. CRISPR-edited crops free to enter market, skip regulation. Nat. Biotechnol 2016; 34:582; PMID:27281401; https://doi.org/10.1038/nbt0616-582
30. Waltz E. A face-lift for biotech rules begins. Nat. Biotechnol 2015; 33:1221-2; PMID:26650002; https://doi.org/10.1038/nbt1215-1221
31. Oji A, Noda T, Fujihara Y, Miyata H, Kim YJ, Muto M, Nozawa K, Matsumura T, Isotani A, Ikawa M. CRISPR/Cas9 mediated genome editing in ES cells and its application for chimeric analysis in mice. Sci. Rep 2016; 6:31666; PMID:27920426; https://doi.org/10.1038/srep31666
32. Bolukbasi MF, Gupta A, Wolfe SA. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat. Methods 2016; 13:41-50; PMID:26716561; https://doi.org/10.1038/nmeth.3684
33. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol 2013; 31:839-43; PMID:23934178; https://doi.org/10.1038/nbt.2673
34. Nowak CM, Lawson S, Zerez M, Bleris L. Guide RNA engineering for versatile Cas9 functionality. Nucleic Acids Res 2016; 44:9555-64; PMID:27733506
35. Kim S, Kim D, Cho SW, Kim J, Kim JS. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 2014; 24:1012-9; PMID:24696461; https://doi.org/10.1101/gr.171322.113
36. Caplan AL, Parent B, Shen M, Plunkett C. No time to waste-the ethical challenges created by CRISPR:CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells. EMBO Rep 2015; 16:1421-6; PMID:26450575; https://doi.org/10.15252/embr.201541337
37. Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science 2016; 351:84-8; PMID:26628643; https://doi.org/10.1126/science.aad5227
38. Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol 2015; 33:187-97; PMID:25513782; https://doi.org/10.1038/nbt.3117
39. Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat. Biotechnol 2015; 33:985-9; PMID:26121415; https://doi.org/10.1038/nbt.3290
40. Rahdar M, McMahon MA, Prakash TP, Swayze EE, Bennett CF, Cleveland DW. Synthetic CRISPR RNA-Cas9-guided genome editing in human cells. Proc. Natl. Acad. Sci. USA 2015; 112:E7110-7.
41. Nihongaki Y, Kawano F, Nakajima T, Sato M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol 2015; 33:755-60; PMID:26076431; https://doi.org/10.1038/nbt.3245
42. Nunez JK, Harrington LB, Doudna JA. Chemical and biophysical modulation of Cas9 for tunable genome engineering. ACS Chem. Biol 2016; 11:681-8; PMID:26857072; https://doi.org/10.1021/acschembio.5b01019
43. Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, et al. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 2015; 348:36-8.
44. Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E, Cohen R, Corn J, Doudna J, Feng G, et al. CRISPR germline engineering - the community speaks. Nat. Biotechnol. 2015; 33:478-86; PMID:25965754; https://doi.org/10.1038/nbt.3227
45. Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J. Don't edit the human germ line. Nature 2015; 519:410-1; PMID:25810189; https://doi.org/10.1038/519410a
46. Cyranoski D. CRISPR gene-editing tested in a person for the first time. Nature 2016; 539:479; PMID:27882996; https://doi.org/10.1038/nature.2016.20988